EMFAT
TCRT icon

Emerald Mutual Fund Advisers Trust’s Alaunos Therapeutics TCRT Stock Holding History

Emerald Mutual Fund Advisers Trust’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,978
Closed -$3.28M – 294
2016
Q2 		$3.28M Buy
3,978
+120
+3% +$131K 0.18% 145
2016
Q1 		$4.29M Sell
3,858
-73
-2% -$74.7K 0.24% 124
2015
Q4 		$4.9M Buy
3,931
+954
+32% +$1.58M 0.26% 119
2015
Q3 		$4.02M Buy
2,977
+401
+16% +$662K 0.26% 117
2015
Q2 		$4.64M Buy
2,576
+224
+10% +$348K 0.36% 96
2015
Q1 		$3.25M Buy
2,352
+857
+57% +$1.27M 0.27% 106
2014
Q4 		$1.14M Buy
+1,495
New +$794K 0.1% 148

Other funds holding TCRT

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BGA
Belmont Global Advisors Dallas, Texas $106M AUM 2.89% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Emerald Mutual Fund Advisers Trust's TCRT Position: Q3 2016 in Review

Emerald Mutual Fund Advisers Trust sold out of Alaunos Therapeutics (TCRT) in Q3 2016, closing a stake of 3,978 shares — an estimated $3.28M sold.

Emerald Mutual Fund Advisers Trust first reported a position in TCRT in Q4 2014 and held it in 7 quarters. The position peaked at $4.9M in Q4 2015. 140 funds tracked by Wall St. Rank hold TCRT as of Q3 2016.

  • Emerald Mutual Fund Advisers Trust reported no remaining Alaunos Therapeutics position as of Q3 2016 after selling out during the quarter.
  • Emerald Mutual Fund Advisers Trust sold 3,978 Alaunos Therapeutics shares in Q3 2016, an estimated $3.28M.
  • Emerald Mutual Fund Advisers Trust first reported a position in Alaunos Therapeutics in Q4 2014 and held it in 7 quarters.
  • Emerald Mutual Fund Advisers Trust's Alaunos Therapeutics position peaked at $4.9M in Q4 2015.
  • 140 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2016.

Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q3 2016, filed 27 Oct 2016.